Clinical trial
Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors
NCT00116896 · OSI Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00116896 |
|---|---|
| Title | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors |
| Official title | Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors |
| Lead sponsor | OSI Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Tumors |
| Intervention type | Drug |
| Interventions | OSI-7904L, Cisplatin |
| Enrollment | 25 |
| Start date | Jun 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Jul 1, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: